sticky E - Mail Iconsticky Call Iconsticky whatsapp icon

Oncology

Breast cancer is a global disease. Though the majority of underlying causes and other features are usually uniform around the world, every region has its own uniqueness for that cancer. Breast cancer has ranked the number one cancer among Indian females with an age-adjusted rate as high as 25.8 per 100,000 women and mortality 12.7 per 100,000 women. Data reports from various latest national cancer registries were compared for incidence and mortality rates. The age-adjusted incidence rate of carcinoma of the breast was found as high as 41 per 100,000 women for Delhi, followed by Chennai (37.9), Bangalore (34.4) and Thiruvananthapuram District (33.7). A statistically significant increase in age-adjusted rate over time (1982-2014) in all the PBCRs namely Bangalore (annual percentage change: 2.84%), Barshi (1.87%), Bhopal (2.00%), Chennai (2.44%), Delhi (1.44%) and Mumbai (1.42%) was observed. Mortality-to-incidence ratio was found to be as high as 66 in rural registries whereas as low as 8 in urban registries. Besides this young age has been found as a major risk factor for breast cancer in Indian women. Breast cancer projection for India during time periods 2020 suggests the number to go as high as 1797900. Better health awareness and availability of breast cancer screening programmes and treatment facilities would cause a favourable and positive clinical picture in the country.
Worries about the trend of breast cancer in India

Increasing incidence of BC in younger age groups

The rising number of cases of breast cancer in India

Late presentation: This directly decreases the long-term survival of the patient

Lack of awareness and Screening: Breast Awareness (Being aware of symptoms of BC, looking out for them regularly, and reporting them on time to a doctor) is the single most important factor responsible for better survival of patients in the west

Aggressive cancers in young: Generally, many cancers in the younger age group tend to be aggressive.

Increasing incidence of BC in younger age groups (30's and 40's)
As per the ICMR data, India had 14 lakh cancer patients in 2016 and this number is expected to increase. The government has laid down four priority cancers — breast cancer, cervical cancer, oral cancer, and lung cancer which together constitute 41 percent of cancer burden, the report mentioned. 

“Breast cancer is currently the most common cancer among Indian women, both in terms of incidence as well as mortality, with proportional prevalence in younger age-groups being higher than the global average. Age-standardized rate is approximately 25.8 per one lakh women and is expected to rise to 35 per one lakh women in 2026,” the report stated.

Non-Invasive image-guided breast Brachytherapy is one of the most desired treatments available in the world's leading Cancer institutes.

AccuBoost ®️ is a non-invasive way to deliver radiation to the site of breast cancer lumpectomy post surgery. AccuBoost ® is an innovation in breast radiotherapy that enables radiation oncologists to target their boost dose to lumpectomy cavity – the tissue that is the most likely site of future cancer recurrence. Treatment enabled by AccuBoost ®️ technology combines a non-invasive method of delivering a targeted beam with the power of real-time image guidance to deliver the radiation dose accurately and reliably to the surgical excision site. Additionally, the AccuBoost ®️ process strongly limits unintentional exposure to otherwise healthy tissue (such as heart, lungs and chest wall) and minimizes radiation-related side effects.

Traditionally, the boost dose, a stronger localized dosage of radiation, is targeted to surgical site using only the surgical scar as an indicator of location. With AccuBoost ®️, the same technology used in mammograms is used to pinpoint the location of the tumour site within the breast. With the breast slightly pulled away from the body as in mammography the boost dose is delivered precisely to the area of lumpectomy from for different angles using the guidance of AccuBoost ®️ real-time digital imaging.